CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference

    2022 International Cancer Immunotherapy Conference Highlights from Day 1

    Back for the first time since the COVID-19 pandemic began, the sixth annual CRI-ENCI-AACR International Cancer Immunotherapy…
    September 29, 2022| Arthur N. Brodsky, PhD
  • The Many Fates of T Cells with CRI Lloyd J. Old STAR Enrico Lugli, PhD

    CRI Lloyd J. Old STAR Enrico Lugli, PhD, is deciphering why some T cells have longevity and…

    April 18, 2022| Arthur N. Brodsky, PhD
  • Improving Cell Therapies by Characterizing Our Immune Arsenal with CRI STAR Dr. Ning Jenny Jiang

    Dr. Ning Jenny Jiang, a CRI Lloyd J. Old STAR at the University of Pennsylvania, is working to…

    November 30, 2021| Arthur N. Brodsky, PhD
  • AACR21 Recap: CRI Scientists Highlight the Latest in ‘Discovery Science Driving Clinical Breakthroughs’

    During AACR21, CRI scientists highlighted how improving our understanding of basic immune biology may enable improved immunotherapies…

    April 16, 2021| Arthur N. Brodsky, PhD
  • CRI Speaks with 2021 Lloyd J. Old Award Recipient Dr. Ton Schumacher

    Dr. Ton Schumacher, 2021 Lloyd J. Old Award recipient, discusses his career accomplishments and the future of…

    April 9, 2021| Arthur N. Brodsky, PhD
  • Meet Dr. Andrea Schietinger, One of Our New Lloyd J. Old STAR Scientists

    Zooming into the tumor and following cell populations over time throughout tumor development or therapeutic response with…

    February 17, 2020| Arthur N. Brodsky, PhD
  • Meet Dr. Alexander Marson, One of CRI’s New Lloyd J. Old STARs

    We spoke with Dr. Alexander Marson to learn more about his work and what he hopes to…

    November 1, 2019| Arthur N. Brodsky, PhD
  • 30 Days of CRI Impact

    Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.

    June 1, 2018| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute